Sebastian Krawiec is Editor at Nutritional Outlook.
The Impossible Burger can now be sold at retail, following FDA’s approval of color additive
August 7th 2019Prior to FDA's amended color additive regulation, soy leghemoglobin, used in the Impossible Burger for meat-like taste, texture, and aroma was only approved in products sold to consumers in cooked form, meaning that Impossible Burger was only available in participating food service locations.
Amarin Pharma petitions Supreme Court to review lower court decision on omega-3 supplements
July 31st 2019Amarin Pharma has filed a petition for certiorari asking the Supreme Court to review a decision made by the U.S. Court of Appeals for the Federal Circuit to uphold a 2017 decision of the International Trade Commission (ITC) not to investigate Amarin’s complaints against manufacturers of omega-3 EPA concentrates.
Geocann launches patented cannabis formulations for food and beverages with higher bioavailability
July 30th 2019Geocann has launched a portfolio of cannabis formulations that utilize the patent-protected VESIsorb delivery system, designed to dramatically improve the absorption and bioavailability of cannabinoids, including cannabidiol (CBD).
Senate hearing looks at hemp-growing obstacles for farmers and state and tribal governments
July 25th 2019The meeting convened federal agencies USDA, FDA, and EPA as well as the testimony of industry stakeholders providing important perspectives when it comes to farming and testing of hemp crops and extracts.
Aker BioMarine secures new patent for Flexitech technology
July 23rd 2019The United States Patent and Trademark Office granted the Aker BioMarine's patent application 15/040,330, which covers Aker’s Flexitech technology, used to make Superba 2 and Superba Boost krill oil products at its Houston facility.
AHPA wants targeted guidance on key NDIN issues, according to comments submitted to FDA
July 18th 2019In public comments submitted to FDA on July 15, 2019, the American Herbal Products Association made a number of suggestions to the agency, which has been in dialogue with the industry to modernize regulation of dietary supplements.
Amarin will file citizen petition to FDA asserting ethyl ester omega-3s are not legally supplements
July 17th 2019In comments submitted to FDA, Amarin Pharma, maker of the omega-3 drug Vascepa, stated its intentions to file a citizen petition to FDA asserting that ethyl ester omega-3s are not legally allowed to be marketed as dietary supplements.
Tomorrow’s Nutrition releases two new supplements featuring SunCran Naturelle
July 17th 2019Two new dietary supplements launched by Tomorrow’s Nutrition include the ingredient SunCran Naturelle, a combination of Taiyo’s Sunfiber and Fruit d’Or Organic Cranberry Juice Powder designed to reduce the risk of urinary tract infections.